キッセイ薬品工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/04/17 | 2,573 | 2,576 | 2,503 | 2,546 | +10 | +0.4% | 71,600 |
2020/04/16 | 2,488 | 2,544 | 2,478 | 2,536 | +32 | +1.3% | 86,900 |
2020/04/15 | 2,499 | 2,527 | 2,485 | 2,504 | +4 | +0.2% | 140,900 |
2020/04/14 | 2,574 | 2,589 | 2,478 | 2,500 | -66 | -2.6% | 109,800 |
2020/04/13 | 2,600 | 2,616 | 2,558 | 2,566 | -69 | -2.6% | 35,200 |
2020/04/10 | 2,509 | 2,635 | 2,496 | 2,635 | +91 | +3.6% | 49,600 |
2020/04/09 | 2,561 | 2,587 | 2,496 | 2,544 | -56 | -2.2% | 64,600 |
2020/04/08 | 2,575 | 2,630 | 2,525 | 2,600 | +3 | +0.1% | 163,200 |
2020/04/07 | 2,568 | 2,608 | 2,527 | 2,597 | +58 | +2.3% | 72,100 |
2020/04/06 | 2,480 | 2,541 | 2,477 | 2,539 | +88 | +3.6% | 98,100 |
2020/04/03 | 2,526 | 2,557 | 2,409 | 2,451 | -73 | -2.9% | 69,700 |
2020/04/02 | 2,594 | 2,628 | 2,524 | 2,524 | -70 | -2.7% | 82,500 |
2020/04/01 | 2,736 | 2,801 | 2,589 | 2,594 | -187 | -6.7% | 82,300 |
2020/03/31 | 2,908 | 2,950 | 2,735 | 2,781 | -152 | -5.2% | 86,700 |
2020/03/30 | 2,814 | 2,949 | 2,756 | 2,933 | +111 | +3.9% | 109,100 |
2020/03/27 | 2,726 | 2,822 | 2,682 | 2,822 | +246 | +9.5% | 187,200 |
2020/03/26 | 2,453 | 2,605 | 2,368 | 2,576 | +92 | +3.7% | 121,000 |
2020/03/25 | 2,599 | 2,599 | 2,409 | 2,484 | +26 | +1.1% | 168,600 |
2020/03/24 | 2,464 | 2,532 | 2,397 | 2,458 | +73 | +3.1% | 139,400 |
2020/03/23 | 2,353 | 2,434 | 2,289 | 2,385 | -18 | -0.7% | 188,100 |
2020/03/19 | 2,315 | 2,431 | 2,259 | 2,403 | +183 | +8.2% | 144,700 |
2020/03/18 | 2,165 | 2,293 | 2,130 | 2,220 | +88 | +4.1% | 190,000 |
2020/03/17 | 2,011 | 2,190 | 2,002 | 2,132 | +60 | +2.9% | 218,800 |
2020/03/16 | 2,139 | 2,172 | 2,069 | 2,072 | -51 | -2.4% | 107,900 |
2020/03/13 | 2,165 | 2,214 | 2,044 | 2,123 | -142 | -6.3% | 174,400 |
2020/03/12 | 2,322 | 2,337 | 2,259 | 2,265 | -97 | -4.1% | 124,200 |
2020/03/11 | 2,397 | 2,430 | 2,362 | 2,362 | -81 | -3.3% | 113,000 |
2020/03/10 | 2,424 | 2,556 | 2,308 | 2,443 | +8 | +0.3% | 97,100 |
2020/03/09 | 2,526 | 2,526 | 2,423 | 2,435 | -141 | -5.5% | 97,500 |
2020/03/06 | 2,622 | 2,624 | 2,566 | 2,576 | -92 | -3.4% | 87,500 |
2020/03/05 | 2,686 | 2,714 | 2,664 | 2,668 | +32 | +1.2% | 103,100 |
2020/03/04 | 2,631 | 2,693 | 2,629 | 2,636 | -45 | -1.7% | 81,000 |
2020/03/03 | 2,765 | 2,769 | 2,668 | 2,681 | -37 | -1.4% | 146,600 |
2020/03/02 | 2,614 | 2,732 | 2,607 | 2,718 | +103 | +3.9% | 169,200 |
2020/02/28 | 2,661 | 2,687 | 2,593 | 2,615 | -96 | -3.5% | 125,000 |
2020/02/27 | 2,743 | 2,744 | 2,708 | 2,711 | -50 | -1.8% | 119,100 |
2020/02/26 | 2,734 | 2,772 | 2,707 | 2,761 | -2 | -0.1% | 116,400 |
2020/02/25 | 2,762 | 2,799 | 2,735 | 2,763 | -99 | -3.5% | 123,300 |
2020/02/21 | 2,845 | 2,877 | 2,834 | 2,862 | +4 | +0.1% | 51,700 |
2020/02/20 | 2,851 | 2,880 | 2,851 | 2,858 | -1 | ±0% | 43,500 |
2020/02/19 | 2,900 | 2,907 | 2,859 | 2,859 | +9 | +0.3% | 69,900 |
2020/02/18 | 2,889 | 2,896 | 2,845 | 2,850 | -68 | -2.3% | 57,300 |
2020/02/17 | 2,963 | 2,963 | 2,907 | 2,918 | -67 | -2.2% | 38,300 |
2020/02/14 | 2,951 | 2,991 | 2,950 | 2,985 | +19 | +0.6% | 52,900 |
2020/02/13 | 2,960 | 2,974 | 2,911 | 2,966 | -22 | -0.7% | 39,000 |
2020/02/12 | 3,040 | 3,040 | 2,965 | 2,988 | -62 | -2% | 60,000 |
2020/02/10 | 3,080 | 3,095 | 3,050 | 3,050 | -65 | -2.1% | 47,400 |
2020/02/07 | 3,095 | 3,115 | 3,070 | 3,115 | +35 | +1.1% | 33,900 |
2020/02/06 | 3,080 | 3,105 | 3,075 | 3,080 | +25 | +0.8% | 77,500 |
2020/02/05 | 3,065 | 3,100 | 3,045 | 3,055 | +30 | +1% | 102,300 |
1251~
1300
件表示中 / 3710件
類似銘柄と比較する
現在ご覧いただいている「キッセイ薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
キッセイ薬 | 429,000円 | +3.6% | +6.1% | 2.80% | 14.45倍 | 0.85倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
ジーエヌアイ | 429,000円 | +21.7% | +999.9% | 0.00% | 17.97倍 | 5.95倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
サワイGHD | 178,600円 | +5.9% | +24.5% | 3.08% | 11.85倍 | 1.12倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
鳥居薬 | 634,000円 | +7.1% | -35.0% | 0.00% | 52.43倍 | 1.47倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
科研薬 | 384,400円 | -6.4% | -71.8% | 4.94% | 42.81倍 | 0.95倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム